Next Generation Sequencing (NGS)

Next Generation Sequencing (NGS)

Sheffield Children’s NHS Foundation Trust Department: Sheffield Diagnostic Genetics Service Title: NGS website document Document reference number: 413.004 NHS Next Generation Sequencing Service at SDGS Table of Contents Table of Contents ................................................................................................................ 1 Testing Workflow ................................................................................................................. 3 Library Preparation ........................................................................................................... 3 Data Analysis ................................................................................................................... 3 Post analysis .................................................................................................................... 4 Confirmation of variants detected by NGS ........................................................................... 4 Next Generation Sequencing Panels ................................................................................... 5 Inborn Errors of Metabolism ............................................................................................. 5 Glycogen Storage Diseases (GSDs) ......................................................................................................................... 5 Fatty Acid Metabolism Disorders ............................................................................................................................... 6 Peroxisomal Disorders ............................................................................................................................................... 7 Hyperammonaemia / Urea Cycle Disorders .............................................................................................................. 8 Rhabdomyolysis / Metabolic Myopathies ................................................................................................................... 9 Cystic fibrosis (newborn screening pilot study) ........................................................................................................ 10 Familial Hypercholesterolemia panel ....................................................................................................................... 10 IEM-mini panel ......................................................................................................................................................... 10 Connective Tissue Disorders ......................................................................................... 11 Ehlers Danlos Syndrome (EDS) .............................................................................................................................. 11 Familial Thoracic Aortic Aneurysm (FTAA) panel .................................................................................................... 11 Osteogenesis Imperfecta (OI) panels ...................................................................................................................... 12 Familial Porencephaly (FP) panel ............................................................................................................................ 12 Alport Syndrome (AP) panel .................................................................................................................................... 13 Bethlem Myopathy panel ......................................................................................................................................... 13 Cutis Laxa (CL) panel .............................................................................................................................................. 13 Stickler Syndrome panel .......................................................................................................................................... 13 Hereditary Cancer Panels .............................................................................................. 14 Breast and Ovarian cancer genes ........................................................................................................................... 14 Colorectal Cancer gene panels ............................................................................................................................... 15 Renal Cancer gene Panel ........................................................................................................................................ 15 Polycystic Disease Panels ............................................................................................. 17 Polycystic Kidney and Liver Disease ....................................................................................................................... 17 Autosomal Dominant Polycystic Kidney Disease – primary panel ........................................................................... 17 Autosomal Recessive Polycystic Kidney Disease.................................................................................................... 17 Autosomal Dominant Polycystic Liver Disease ........................................................................................................ 17 Autosomal Dominant Tubulointerstitial Kidney Disease (aka Medullary cystic & Glomerulocystic kidney disease) . 17 Polycystic Kidney and Liver Disease full panel ........................................................................................................ 17 Neurogenetic Disorders .................................................................................................. 19 Hereditary Spastic Paraparesis 88 gene panel ........................................................................................................ 19 Spinal Muscular Atrophy 29 gene panel .................................................................................................................. 21 Familial Amyotrophic Lateral Sclerosis with or without Frontotemporal Dementia 42 gene panel ........................... 23 Dementia 27 gene panel .......................................................................................................................................... 24 Hereditary Dystonia 73 gene panel.......................................................................................................................... 26 Hereditary Parkinsonism 53 gene panel .................................................................................................................. 28 Hereditary Chorea 30 gene panel ............................................................................................................................ 30 Abnormal Metal Transport 9 gene panel .................................................................................................................. 31 Hemiplegic Migraine 10 gene panel......................................................................................................................... 32 Date of issue: 18 Nov 2019 Version number: 7 Author: Miranda Durkie Authorised by: Richard Kirk Page 1 of 42 Sheffield Children’s NHS Foundation Trust Department: Sheffield Diagnostic Genetics Service Title: NGS website document Document reference number: 413.004 Episodic Ataxia 11 gene panel ................................................................................................................................ 32 Hereditary Ataxia (Stage 1) 107 gene panel ............................................................................................................ 33 Hereditary Ataxia (Stage 2) 54 gene panel .............................................................................................................. 37 Haematology disorders .................................................................................................. 40 Bleeding & Thrombotic disorders ............................................................................................................................. 40 Bone Marrow Failure Disorders ............................................................................................................................... 40 Oncology ........................................................................................................................ 42 Date of issue: 18 Nov 2019 Version number: 7 Author: Miranda Durkie Authorised by: Richard Kirk Page 2 of 42 Sheffield Children’s NHS Foundation Trust Department: Sheffield Diagnostic Genetics Service Title: NGS website document Document reference number: 413.004 Testing Workflow Library Preparation SureSelect/Illumina Shearing of genomic DNA using the Covaris E220 sonicator. End repair, A tailing and ligation of adaptors using SureSelectXT library system (Agilent Technologies). Enrichment by SureSelect target enrichment (Agilent Technologies) using custom in house designed probes. Samples have barcode tags added following target enrichment. Sequencing on the Illumina HiSeq using the HiSeq Rapid SBS Kit v2 performing 2 x 108 bp paired end reads. AmpliSeq/Ion Torrent Generate amplicon libraries using Ion AmpliSeq (Thermo Fisher Scientific) primer pools, and add patient specific barcodes. Ion Chef System provides automated, high-throughput preparation of template- positive Ion Sphere Particles (ISPs) and Ion 520, 530 or 540 chip loading. Sequencing on the Ion S5 or S5 Prime system. Data Analysis Based on the open source ‘Best Practices’ workflow by the Broad Institute (for additional information, see http://www.broadinstitute.org/gatk/guide/best-practices).

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    42 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us